公开(公告)号：US11053304B1

公开(公告)日：2021-07-06

申请号：US15931648

申请日：2020-05-14

Applicant: Centivax, Inc.

Inventor： Jacob Glanville ,  Shahrad Daraeikia ,  I-Chieh Wang ,  Sindy Andrea Liao-Chan ,  Jean-Philippe Bürckert ,  Sawsan Youssef

IPC: C07K16/10 ,  A61K39/42 ,  G01N33/569 ,  A61P31/14 ,  A61K39/00

Abstract: This disclosure provides antibodies and antigen-binding fragments that are derived from 6nb6 and that can be administered to an individual that is infected or suspected of being infected with a virus. Antibodies and antigen-binding fragments herein can be capable of treating or curing the virus, and which may provide protection against the virus for up to several weeks. Antibodies and antigen-binding fragments herein can be used to diagnose a SARS CoV 2 infection.

公开(公告)号：US11021532B1

公开(公告)日：2021-06-01

申请号：US15931654

申请日：2020-05-14

Applicant: Centivax, Inc.

Inventor： Jacob Glanville ,  Shahrad Daraeikia ,  I-Chieh Wang ,  Sindy Andrea Liao-Chan

IPC: A61K39/42 ,  C07K16/10 ,  G01N33/68 ,  A61P31/14 ,  A61K39/00 ,  A61K45/06

Abstract: This disclosure provides superhuman antibodies and antigen-binding fragments that can be administered to an individual that is infected or suspected of being infected with a virus. Superhuman antibodies and antigen-binding fragments provided herein can be capable of treating or curing the virus, and which may provide protection against the virus for up to at least several weeks. Superhuman antibodies and antigen-binding fragments provided herein can be used to diagnose a SARS Cov-2 infection.

公开(公告)号：US11021531B1

公开(公告)日：2021-06-01

申请号：US15931643

申请日：2020-05-14

Applicant: Centivax, Inc.

Inventor： Jacob Glanville ,  Shahrad Daraeikia ,  I-Chieh Wang ,  Sindy Andrea Liao-Chan ,  Jean-Philippe Bürckert ,  Sawsan Youssef

IPC: A61K39/42 ,  C07K16/10 ,  A61P31/14 ,  A61K39/00

Abstract: This disclosure provides antibodies and antigen-binding fragments that are derived from 2ghw and that can be administered to an individual that is infected or suspected of being infected with a virus. Antibodies and antigen-binding fragments provided herein can be capable of treating or curing the virus, and which may provide protection against the virus for up to several weeks. Antibodies and antigen-binding fragments provided herein can be used to diagnose a SARS-Cov-2 infection.